Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway

Stem Cell Research and Therapy

Volumn 5, Issue 4, 2014, Pages

  Passipieri, Juliana A ^a,b   Kasai Brunswick, Tais H ^a,b   Suhett, Grazielle ^a   Martins, Andreza B ^a,b   Brasil, Guilherme V ^a   Campos, Dilza B ^a   Rocha, Nazareth N ^c   Ramos, Isalira P ^a,d   Mello, Debora B ^a   Rodrigues, Deivid C ^a   Christie, Beatriz B ^a   Silva Mendes, Bernardo J ^a   Balduíno, Alex ^e   Sá, Renato M ^f   Lopes, Laudelino M ^f,g   Goldenberg, Regina C ^a,d   Campos De Carvalho, Antonio C ^a,b,d   Carvalho, Adriana B ^a,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CARDIOLOGIA   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d Instituto Nacional de Ciência E Tecnologia de Biologia Estrutural E Bioimagem   (Brazil)

^e VEIGA DE ALMEIDA UNIVERSITY   (Brazil)

^f Centro Pré Natal de Diagnóstico e Tratamento Clínica Perinatal   (Brazil)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORION VILLUS; CHORIONIC PLATE; COLONY FORMING UNIT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FIBROBLAST; GENETIC STABILITY; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PLACENTA; PLACENTA DERIVED MESENCHYMAL STEM CELL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL SHAPE; HEART MUSCLE; HEART STROKE VOLUME; HEART VOLUME; MESENCHYMAL STROMA CELL; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

ANIMALS; CARDIAC VOLUME; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; FEMALE; HUMANS; INSULIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PHENOTYPE; SIGNAL TRANSDUCTION; STROKE VOLUME;

EID: 84907462695     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt490     Document Type: Article

References (68)

1. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Soleymaninejadian E, Pramanik K, Samadian E, Am J Reprod Immunol 2012 67 1 8 21951555
2. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814
3. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, Circulation 2002 105 93 98 10.1161/hc0102.101442 11772882
4. Fat tissue: an underappreciated source of stem cells for biotechnology. Fraser JK, Wulur I, Alfonso Z, Hedrick MH, Trends Biotechnol 2006 24 150 154 10.1016/j.tibtech.2006.01.010 16488036
5. A method to isolate and culture expand human dental pulp stem cells. Gronthos S, Arthur A, Bartold PM, Shi S, Methods Mol Biol 2011 698 107 121 10.1007/978-1-60761-999-4-9 21431514
6. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Caplan AI, J Cell Physiol 2007 213 341 347 10.1002/jcp.21200 17620285
7. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F, Haematologica 2001 86 1099 1100 11602418
8. Stem cells from fetal membranes-a workshop report. Hemberger M, Yang W, Natale D, Brown TL, Dunk C, Gargett CE, Tanaka S, Placenta 2008 29 17 S19 18155293
9. Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells. Miranda-Sayago JM, Fernandez-Arcas N, Benito C, Reyes-Engel A, Carrera J, Alonso A, Cytotherapy 2011 13 572 581 10.3109/14653249.2010.547466 21208022
10. Transcriptome analysis of common gene expression in human mesenchymal stem cells derived from four different origins. Wang TH, Lee YS, Hwang SM, Methods Mol Biol 2011 698 405 417 10.1007/978-1-60761-999-4-29 21431534
11. Harvesting the potential of the human umbilical cord: isolation and characterisation of four cell types for tissue engineering applications. Hayward CJ, Fradette J, Galbraith T, Remy M, Guignard R, Gauvin R, Germain L, Auger FA, Cells Tissues Organs 2013 197 37 54 10.1159/000341254 22965075
12. Engraftment potential of human amnion and chorion cells derived from term placenta. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, Arienti D, Calamani F, Zatti D, Paul P, Albertini A, Zorzi F, Cavagnini A, Candotti F, Wengler GS, Parolini O, Transplantation 2004 78 1439 1448 10.1097/01.TP.0000144606.84234.49 15599307
13. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K, Stem Cells 2004 22 649 658 10.1634/stemcells.22-5-649 15342929
14. Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling. Liu CM, Chang CH, Yu CH, Hsu CC, Huang LL, Cell Tissue Res 2009 336 465 475 10.1007/s00441-009-0780-3 19350274
15. Isolation of multipotent cells from human term placenta. Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC, Stem Cells 2005 23 3 9 10.1634/stemcells.2004-0098 15625118
16. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, Abele H, Schewe B, Just L, Skutella T, Buhring HJ, Differentiation 2007 75 279 291 10.1111/j.1432-0436.2006.00139.x 17288545
17. Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats. Chen CP, Liu SH, Huang JP, Aplin JD, Wu YH, Chen PC, Hu CS, Ko CC, Lee MY, Chen CY, Hum Reprod 2009 24 154 165 18845668
18. Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cells. Zhang X, Soda Y, Takahashi K, Bai Y, Mitsuru A, Igura K, Satoh H, Yamaguchi S, Tani K, Tojo A, Takahashi TA, Biochem Biophys Res Commun 2006 351 853 859 10.1016/j.bbrc.2006.10.125 17094946
19. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, Takahashi TA, Biochem Biophys Res Commun 2006 340 944 952 10.1016/j.bbrc.2005.12.091 16403457
20. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Altalabani AA, Knawy BA, Stem Cell Rev 2013 9 16 31 10.1007/s12015-012-9385-4 22628114
21. Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion. Poloni A, Maurizi G, Babini L, Serrani F, Berardinelli E, Mancini S, Costantini B, Discepoli G, Leoni P, Cell Transplant 2011 20 643 654 10.3727/096368910X536518 21054927
22. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV, Am J Obstet Gynecol 2006 194 664 673 10.1016/j.ajog.2006.01.101 16522395
23. Human placenta feeder layers support undifferentiated growth of primate embryonic stem cells. Miyamoto K, Hayashi K, Suzuki T, Ichihara S, Yamada T, Kano Y, Yamabe T, Ito Y, Stem Cells 2004 22 433 440 10.1634/stemcells.22-4-433 15277690
24. 'Working' cardiomyocytes exhibiting plateau action potentials from human placenta-derived extraembryonic mesodermal cells. Okamoto K, Miyoshi S, Toyoda M, Hida N, Ikegami Y, Makino H, Nishiyama N, Tsuji H, Cui CH, Segawa K, Uyama T, Kami D, Miyado K, Asada H, Matsumoto K, Saito H, Yoshimura Y, Ogawa S, Aeba R, Yozu R, Umezawa A, Exp Cell Res 2007 313 2550 2562 10.1016/j.yexcr.2007.04.028 17544394
25. Ex vitro expansion of human placenta-derived mesenchymal stem cells in stirred bioreactor. Yu Y, Li K, Bao C, Liu T, Jin Y, Ren H, Yun W, Appl Biochem Biotechnol 2009 159 110 118 10.1007/s12010-009-8556-5 19266320
26. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Brooke G, Rossetti T, Pelekanos R, Ilic N, Murray P, Hancock S, Antonenas V, Huang G, Gottlieb D, Bradstock K, Atkinson K, Br J Haematol 2009 144 571 579 10.1111/j.1365-2141.2008.07492.x 19077161
27. Isolation and characterization of mesenchymal cells from human fetal membranes. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O, J Tissue Eng Regen Med 2007 1 296 305 10.1002/term.40 18038420
28. UN targets top killers. Butler D, Nature 2011 477 260 261 10.1038/477260a 21921892
29. Autologous transplantation of bone marrow cells improves damaged heart function. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ, Circulation 1999 100 I247 II256 10567312
30. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC, J Thorac Cardiovasc Surg 2000 120 999 1005 10.1067/mtc.2000.110250 11044327
31. Bone marrow cells regenerate infarcted myocardium. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P, Nature 2001 410 701 705 10.1038/35070587 11287958
32. Bone marrow cells adopt the cardiomyogenic fate in vivo. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas ME, Gonzalez A, Rizzi R, Small N, Muraski J, Alvarez R, Chen X, Urbanek K, Bolli R, Houser SR, Leri A, Sussman M, Anversa P, Proc Natl Acad Sci U S A 2007 104 17783 17788 10.1073/pnas.0706406104 17965233
33. Little evidence for developmental plasticity of adult hematopoietic stem cells. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL, Science 2002 297 2256 2259 10.1126/science.1074807 12215650
34. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ, Nature 2004 428 664 668 10.1038/nature02446 15034593
35. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC, Nature 2004 428 668 673 10.1038/nature02460 15034594
36. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ, Nat Med 2005 11 367 368 10.1038/nm0405-367 15812508
37. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE, Mol Ther 2006 14 840 850 10.1016/j.ymthe.2006.05.016 16965940
38. Functional and transcriptomic recovery of infarcted mouse myocardium treated with bone marrow mononuclear cells. Lachtermacher S, Esporcatte BL, Fortes Fda S, Rocha NN, Montalvao F, Costa PC, Belem L, Rabischoffisky A, Faria Neto HC, Vasconcellos R, Iacobas DA, Iacobas S, Spray DC, Thomas NM, Goldenberg RC, de Carvalho AC, Stem Cell Rev 2012 8 251 261 10.1007/s12015-011-9282-2 21671060
39. Transplantation of bone marrow stromal cells for treatment of central nervous system diseases. Chopp M, Li Y, Adv Exp Med Biol 2006 585 49 64 17120776
40. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI, Am J Physiol Lung Cell Mol Physiol 2010 299 760 L770 10.1152/ajplung.00182.2009 20817776
41. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. Ventura C, Cantoni S, Bianchi F, Lionetti V, Cavallini C, Scarlata I, Foroni L, Maioli M, Bonsi L, Alviano F, Fossati V, Bagnara GP, Pasquinelli G, Recchia FA, Perbellini A, J Biol Chem 2007 282 14243 14252 10.1074/jbc.M609350200 17363374
42. Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study. Simioniuc A, Campan M, Lionetti V, Marinelli M, Aquaro GD, Cavallini C, Valente S, Di Silvestre D, Cantoni S, Bernini F, Simi C, Pardini S, Mauri P, Neglia D, Ventura C, Pasquinelli G, Recchia FA, Cardiovasc Res 2011 90 546 556 10.1093/cvr/cvr018 21257613
43. Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijkens B, Martens AC, Buhring HJ, Doevendans PA, Sluijter JP, J Cell Mol Med 2012 16 1827 1839 10.1111/j.1582-4934.2011.01455.x 21973026
44. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM, Proc Natl Acad Sci U S A 2005 102 11474 11479 10.1073/pnas.0504388102 16061805
45. A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization. Islam MN, Paquet N, Fox D 3rd, Dray E, Zheng XF, Klein H, Sung P, Wang W, J Biol Chem 2012 287 23808 23818 10.1074/jbc.M112.375014 22645136
46. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. D'Angiolella V, Donato V, Forrester FM, Jeong YT, Pellacani C, Kudo Y, Saraf A, Florens L, Washburn MP, Pagano M, Cell 2012 149 1023 1034 10.1016/j.cell.2012.03.043 22632967
47. Cyclin F disruption compromises placental development and affects normal cell cycle execution. Tetzlaff MT, Bai C, Finegold M, Wilson J, Harper JW, Mahon KA, Elledge SJ, Mol Cell Biol 2004 24 2487 2498 10.1128/MCB.24.6.2487-2498.2004 14993286
48. Animal models of heart failure: a scientific statement from the American Heart Association. Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA, Koch WJ, Circ Res 2012 111 131 150 10.1161/RES.0b013e3182582523 22595296
49. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ, J Neurosci 2010 30 9603 9611 10.1523/JNEUROSCI.1835-10.2010 20631189
50. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Lee SR, Lee SH, Moon JY, Park JY, Lee D, Lim SJ, Jeong KH, Park JK, Lee TW, Ihm CG, Ren Fail 2010 32 840 848 10.3109/0886022X.2010.494803 20662698
51. In vivo bioluminescence for tracking cell fate and function. de Almeida PE, van Rappard JR, Wu JC, Am J Physiol Heart Circ Physiol 2011 301 663 H671 10.1152/ajpheart.00337.2011 21666118
52. Immunomodulation by mesenchymal stem cells and clinical experience. Le Blanc K, Ringden O, J Intern Med 2007 262 509 525 10.1111/j.1365-2796.2007.01844.x 17949362
53. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Li J, Ezzelarab MB, Cooper DK, Xenotransplantation 2012 19 273 285 10.1111/xen.12000 22978461
54. Assessment and optimization of cell engraftment after transplantation into the heart. Terrovitis JV, Smith RR, Marban E, Circ Res 2010 106 479 494 10.1161/CIRCRESAHA.109.208991 20167944
55. Paracrine mechanisms in adult stem cell signaling and therapy. Gnecchi M, Zhang Z, Ni A, Dzau VJ, Circ Res 2008 103 1204 1219 10.1161/CIRCRESAHA.108.176826 19028920
56. Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. Lionetti V, Bianchi G, Recchia FA, Ventura C, Heart Fail Rev 2010 15 531 542 10.1007/s10741-010-9165-7 20364318
57. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, Marban E, Circ Res 2010 106 971 980 10.1161/CIRCRESAHA.109.210682 20110532
58. Heart to heart: the elusive mechanism of cell therapy. Marban E, Cheng K, Circulation 2010 121 1981 1984 10.1161/CIRCULATIONAHA.110.952580 20421516
59. The promise and perils of stem cell therapeutics. Daley GQ, Cell Stem Cell 2012 10 740 749 10.1016/j.stem.2012.05.010 22704514
60. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W, J Am Coll Cardiol 2009 54 2277 2286 10.1016/j.jacc.2009.06.055 19958962
61. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes. Lee HJ, Jung J, Cho KJ, Lee CK, Hwang SG, Kim GJ, Differentiation 2012 84 223 231 10.1016/j.diff.2012.05.007 22885322
62. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells. Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ, Cell Tissue Res 2011 346 53 64 10.1007/s00441-011-1249-8 21987220
63. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, Zhang X, Cell Biol Int 2006 30 681 687 10.1016/j.cellbi.2006.03.009 16870478
64. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Chien CC, Yen BL, Lee FK, Lai TH, Chen YC, Chan SH, Huang HI, Stem Cells 2006 24 1759 1768 10.1634/stemcells.2005-0521 16822884
65. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Prigozhina TB, Khitrin S, Elkin G, Eizik O, Morecki S, Slavin S, Exp Hematol 2008 36 1370 1376 10.1016/j.exphem.2008.04.022 18619727
66. Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, Zisch AH, Malek A, Am J Obstet Gynecol 2010 202 193 e191 193 e113
67. Oct4 and its pseudogenes confuse stem cell research. Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kogler G, Cell Stem Cell 2007 1 364 366 10.1016/j.stem.2007.09.003 18371374
68. Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of the emperor's new clothes. Ryan JM, Pettit AR, Guillot PV, Chan JK, Fisk NM, Stem Cell Reviews 2013 9 408 421 10.1007/s12015-011-9336-5 22161644